Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5051
Invesco MSCI Global Timber ETF
CUT
$29.3M
| $1.11M | ﹤0.01% |
39,885
-2,225
| -5% | -$62.1K |
2013 Q2
52 quarters
|
|
5052
iShares Mortgage-Backed Securities Active ETF
MBBA
$149M
| $1.11M | ﹤0.01% |
22,340
-225
| -1% | -$11.2K |
2026 Q1
1 quarter
|
|
5053
Materialise
MTLS
$465M
| $1.11M | ﹤0.01% |
149,415
-56,937
| -28% | -$337K |
2019 Q1
29 quarters
|
|
5054
Riskified
RSKD
$1.09B
| $1.11M | ﹤0.01% |
220,161
+70,501
| +47% | +$329K |
2021 Q3
19 quarters
|
|
5055
Editas Medicine
EDIT
$367M
| $1.11M | ﹤0.01% |
342,165
-69,027
| -17% | -$202K |
2016 Q1
41 quarters
|
|
5056
Eagle Bancorp Montana
EBMT
$165M
| $1.11M | ﹤0.01% |
46,234
+13
| +0% | +$292 |
2013 Q4
50 quarters
|
|
5057
Pacer Nasdaq 100 Top 50 Cash Cows Growth Leaders ETF
QQQG
$47.2M
| $1.1M | ﹤0.01% |
+33,399
| New | +$955K |
2026 Q2
0 quarters
|
|
5058
State Street Bridgewater All Weather ETF
ALLW
$1.81B
| $1.1M | ﹤0.01% |
37,612
+27,612
| +276% | +$820K |
2025 Q4
2 quarters
|
|
5059
ProShares VIX Mid-Term Futures ETF
VIXM
$48.7M
| $1.1M | ﹤0.01% |
76,401
-68,832
| -47% | -$1.08M |
2013 Q2
52 quarters
|
|
5060
Harbor Human Capital Factor US Large Cap ETF
HAPI
$511M
| $1.1M | ﹤0.01% |
24,689
-7,880
| -24% | -$341K |
2025 Q4
2 quarters
|
|
5061
Virtus Biotech ETF
BBP
$127M
| $1.09M | ﹤0.01% |
11,370
-4,641
| -29% | -$404K |
2015 Q3
43 quarters
|
|
5062
First National Corp
FXNC
$270M
| $1.09M | ﹤0.01% |
36,407
+14,663
| +67% | +$416K |
2019 Q2
28 quarters
|
|
5063
Korea Fund
KF
$229M
| $1.09M | ﹤0.01% |
14,526
-16,548
| -53% | -$1.07M |
2013 Q2
52 quarters
|
|
5064
AB Conservative Buffer ETF
BUFC
$1.11B
| $1.09M | ﹤0.01% |
25,657
-47
| -0.2% | -$1.98K |
2024 Q2
8 quarters
|
|
5065
Viomi Technology
VIOT
$94.3M
| $1.09M | ﹤0.01% |
1,392,995
+866,283
| +164% | +$834K |
2018 Q3
31 quarters
|
|
5066
Greene County Bancorp
GCBC
$592M
| $1.09M | ﹤0.01% |
32,344
-2,143
| -6% | -$55.1K |
2014 Q1
49 quarters
|
|
5067
Commerce.com Inc Series 1
CMRC
$292M
| $1.08M | ﹤0.01% |
364,667
-29,632
| -8% | -$84.9K |
2020 Q3
23 quarters
|
|
5068
JELD-WEN Holding
JELD
$117M
| $1.08M | ﹤0.01% |
719,515
+508,598
| +241% | +$784K |
2017 Q1
37 quarters
|
|
5069
Tortoise Energy ETF
TNGY
$588M
| $1.07M | ﹤0.01% |
110,409
+341
| +0.3% | +$3.45K |
2025 Q2
4 quarters
|
|
5070
Greenfire Resources
GFR
$1.57B
| $1.07M | ﹤0.01% |
189,467
+109,511
| +137% | +$651K |
2024 Q2
8 quarters
|
|
5071
MiniMed Group Inc
MMED
$4.91B
| $1.06M | ﹤0.01% |
71,080
+27,942
| +65% | +$368K |
2026 Q1
1 quarter
|
|
5072
Grupo Aeromexico SAB de CV
AERO
$2.36B
| $1.06M | ﹤0.01% |
58,934
-320,168
| -84% | -$5.14M |
2025 Q4
2 quarters
|
|
5073
Timberland Bancorp
TSBK
$357M
| $1.06M | ﹤0.01% |
23,617
+1,552
| +7% | +$64.2K |
2013 Q4
50 quarters
|
|
5074
Accendra Health
ACH
$19.4M
| $1.05M | ﹤0.01% |
307,701
-117,077
| -28% | -$364K |
2013 Q2
52 quarters
|
|
5075
Travelzoo
TZOO
$50.3M
| $1.05M | ﹤0.01% |
89,585
+22,153
| +33% | +$204K |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.